Status:
COMPLETED
Margin Status After Pancreaticoduodenectomy for Cancer
Lead Sponsor:
Campus Bio-Medico University
Collaborating Sponsors:
Humanitas Hospital, Italy
Azienda Ospedaliero, Universitaria Pisana
Conditions:
Pancreatic Cancer
Cholangiocarcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This multicentric prospective randomized controlled trial (RCT) compares the Leeds Pathology Protocol (LEEPP) with other "conventional" pathological protocol of PD specimen for periampullary cancer. O...
Eligibility Criteria
Inclusion
- pancreaticoduodenectomy for periampullary cancer
Exclusion
- diagnosis of neuroendocrine neoplasm;
- previous pancreatic surgery;
- frozen section of each transection margins not performed or presence of positive transection margins without further resection (R1 intraoperative resection);
- presence of macroscopic residual tumor (R2 resection).
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT03267966
Start Date
March 1 2013
End Date
June 1 2019
Last Update
February 6 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.